Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular Cholangiocarcinoma: Working Group Report From the ILTS Transplant Oncology Consensus Conference

Transplantation. 2020 Jun;104(6):1125-1130. doi: 10.1097/TP.0000000000003212.

Abstract

Liver transplantation for cholangiocarcinoma has been an absolute contraindication worldwide due to poor results. However, in recent years and thanks to improvements of patient management and treatments of this cancer, this indication has been revisited. This consensus paper, approved by the International Liver Transplant Society, aims to provide a collection of expert opinions, consensus, and best practices surrounding liver transplantation for cholangiocarcinoma.

Publication types

  • Review

MeSH terms

  • Bile Duct Neoplasms / mortality
  • Bile Duct Neoplasms / therapy*
  • Chemoradiotherapy, Adjuvant / methods
  • Chemoradiotherapy, Adjuvant / standards
  • Cholangiocarcinoma / mortality
  • Cholangiocarcinoma / therapy*
  • Consensus*
  • Humans
  • Liver Transplantation / standards*
  • Medical Oncology / standards*
  • Neoadjuvant Therapy / methods
  • Neoadjuvant Therapy / standards
  • Practice Guidelines as Topic
  • Preoperative Care / methods
  • Preoperative Care / standards
  • Survival Rate
  • Treatment Outcome